Quantcast

Latest Diabetes Stories

2014-09-12 12:24:54

WINSTON-SALEM, N.C., Sept. 12, 2014 /PRNewswire/ -- Cilina Murphy, a rising junior at Cherokee (N.C.) High School, already knows her senior project is going to be about diabetes. http://photos.prnewswire.com/prnvar/20140911/145576 She has a personal stake in it: Her grandmother, great-grandmother, an aunt and several cousins have Type 2 diabetes. "I see my grandma and great-grandma take insulin shots and what looks like 500 pills, and I really don't want to end up like that," said...

2014-09-11 23:06:37

Transparency Market Research published a new report "Global and China Insulin Market: Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume) 2013 - 2019" to its report store. Albany, New York (PRWEB) September 11, 2014 According to a new market report published by Transparency Market Research "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size,...

2014-09-11 16:28:19

- Oral presentation 9/19: interim Phase 3 results for ITCA 650 among patients with high baseline (HBL) HbA1c levels between 10-12% showed dramatic HbA1c reductions, even in patients with high HbA1c despite multi-drug therapy BOSTON, Sept. 11, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced its participation in the 50(th) Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place in Vienna September 15 -19. Intarcia's lead product...

2014-09-11 16:26:05

Results from Phase 2b Clinical Study in Patients with Type 2 Diabetes Provide Evidence that SGLT1 inhibition with LX4211 Provides a Clinically Meaningful Benefit THE WOODLANDS, Texas, Sept. 11, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced a publication in the online edition of the American Diabetes Association's journal, Diabetes Care, entitled, "Greater Dose-Ranging Effects on A1C Levels Than on Glucosuria With LX4211, a Dual Inhibitor of Sodium...

2014-09-10 23:08:06

"Five Things Women with Diabetes (WWD) Should Know about Menopause" Durham, NC (PRWEB) September 10, 2014 DiabetesSisters, the nation’s leading voice for women with diabetes, is pleased to announce that its next webinar in the Life Class Webinar Series will take place on Wednesday, September 17 at 4 PM EDT. The webinar is entitled "Five Things Women with Diabetes (WWD) Should Know about Menopause” and it's free and open to the first 100 registrants. Moderated by...

2014-09-10 16:26:29

SAN DIEGO, Sept. 10, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a stem cell-derived islet replacement therapy for the treatment of diabetes, called VC-01, announced today that it has been selected to receive a $16.6 million Accelerated Development Pathway Award from the California Institute for Regenerative Medicine (CIRM). According to CIRM, the Accelerated Development Awards were created to "provide selected applicants who are...

2014-09-10 08:32:28

PALO ALTO, Calif., Sept. 10, 2014 /PRNewswire/ -- Livongo Health(TM), which launched earlier today, is announcing the availability of Livongo for Diabetes, its new consumer digital health platform that provides real-time information, personalized tools and a connected support network to empower people with diabetes to live better. Diabetes is a 24/7 disease that takes significant effort to manage and there is no right answer for everyone. It requires a simple approach that focuses...

2014-09-10 08:32:24

Company Unveils Unique Platform to Combine Cloud-Based Analytics with the First FDA-Cleared Interactive Blood Glucose Meter PALO ALTO, Calif., Sept. 10, 2014 /PRNewswire/ -- Livongo Health(TM), a consumer digital health company, launched today with a vision to empower people with chronic conditions to live better through the combined power of technology, real-time personalized information, and support from their chosen care team. "We're reinventing the way people with chronic...

2014-09-10 08:29:58

ROSH HA-AYIN, Israel, September 10, 2014 /PRNewswire/ -- Beta-O2 announced today that it has received a $500K grant from JDRF. The grant will be used to help fund a $1M pilot human study of Beta-O2's ssAir bio-artificial pancreas, in development as a treatment and potential cure for type 1 diabetes (T1D). The two-year study, which will enroll eight participants at Uppsala University Hospital in Sweden, will evaluate the safety, survival and function of implanted human islets...

prediabetes cancer risk
2014-09-10 06:33:34

April Flowers for redOrbit.com - Your Universe Online Professor Yuli Huang of The First People's Hospital of Shunde, China, worked with a team of researchers to conduct a meta-analysis of studies concerning prediabetes. Their findings, published in Diabetologia, are based on 16 studies and 891,426 participants from around the world. The literature review revealed that people with prediabetes have a 15 percent higher risk of developing cancer — and that the level of risk differs depending...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related